---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-120763"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T05:00:30.843247+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Jaguar Health reduces royalty debt by $1.016M via equity exchanges; Q1 results released

## Summary
- Issued 60,000 shares to Iliad for $466,200 reduction in October 2020 royalty interest.
- Exchanged all 99.3822 Series J shares for Series L perpetual preferred stock with Streeterville.
- Issued 22 Series L shares to Iliad for $550,000 royalty reduction; Series L pays 0%/10%/15% preferred return.
- Q1 2025 earnings press released (financial details not provided in filing).
- Company will seek stockholder approval to exceed Nasdaq exchange cap for Series L conversions.

## SEC filing metadata
- accession: 0001193125-25-120763
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 1.01, 2.02, 2.03, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312525120763/0001193125-25-120763-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312525120763/d63848d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-120763
- JSON: https://secwatch.observer/filing/0001193125-25-120763.json
- Plain text: https://secwatch.observer/filing/0001193125-25-120763.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.